Uncategorized

The massive PBM is pivoting to a cost-based reimbursement model, which it says will reduce variation in how pharmacies are paid. Pharmacy groups say that depends on the specifics of Optum Rx’s plan.

DispatchHealth CEO Jennifer Webster will lead the combined company once the deal closes, which is expected in mid-2025.

This is the third indication for Fabhalta after Novartis won FDA approval of the small molecule in paroxysmal nocturnal hemoglobinuria and primary immunoglobulin A nephropathy.

Johnson & Johnson follows Eli Lilly in spending billions on U.S. manufacturing after President Donald Trump threatened major tariffs on pharmaceutical products. Pfizer has also promised a similar commitment.

The alert describes a problem that can lead to excessive pressure in the kidney during procedures to remove urinary stones.

Adaptimmune is rolling out its T cell therapy Tecelra for synovial sarcoma, recording $1.2 million in sales since its approval in August 2024. Nevertheless, it is pausing development of two oncology assets to save money.

After withdrawing its nomination for Dave Weldon last week, the Trump administration is now reportedly considering Texas Republican Michael Burgess to head the CDC.

The label expansion couls help J&J establish Tremfya as a successor to Stelara, which is now facing a growing biosimilar challenge.

Esta imagen, que parece sacada de una película de ciencia-ficción, es real, aunque la fotografía se tomó con muy poca luz y con un tiempo de exposición muy largo. En ella podemos ver una parte de la Vía Láctea recortada por el borde de la Tierra, como …

  En un panorama digital en constante evolución, los criptocasinos han irrumpido con fuerza en el mercado español, prometiendo revolucionar la forma en que apostamos. Mientras las autoridades mantienen su lucha contra el casino online sin licencia que opera al margen de la reg …